The limitation of this study was, along with the limit of a cross-sectional investigation, the fact that other health factors, such as benign prostate disorders (benign prostate hyperplasia, prostatitis and others), might affect serum PSA levels, could not be completely controlled. This evidence concerns the gene KLK3 and prostatitis.